DNAGinkgo+PlatformTWSTTwist+SynthesisABSIAbsci+AIDesignCRSPCRISPR Therapeutics+EditBEAMBeam+BaseEditNTLAIntellia+InVivoCRBUCaribou+CellTherapyRXRXRecursion+AIILMNIllumina+SeqEDITEditas+GeneFUND.YTD2025$17.3B.Raised
Terminal/Companies/Ginkgo Bioworks
publicFounded 2008

Ginkgo Bioworks

HQ: Boston, MA, USACEO: Jason KellyHeadcount: 1000+ginkgobioworks.com
Funding Summary
Total Funding
$2.8B+
Latest Valuation
~$1.5B (public market cap, 2025)
About

The largest cell programming platform in synthetic biology, operating massive automated foundries for organism engineering across pharma, agriculture, food, and materials. Also operates Concentric for biosecurity monitoring.

platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →
Referenced In